Cargando…
Modeling Pharmacokinetic Profiles for Assessment of Anti-Cancer Drug on a Microfluidic System
The pharmacokinetic (PK) properties of drug, which include drug absorption and excretion, play an important role in determining the in vivo pharmaceutical activity. However, current in vitro systems that model PK profiles are often limited by the in vivo-like concentration profile of a drug. Herein,...
Autores principales: | Guo, Yaqiong, Deng, Pengwei, Chen, Wenwen, Li, Zhongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344513/ https://www.ncbi.nlm.nih.gov/pubmed/32486116 http://dx.doi.org/10.3390/mi11060551 |
Ejemplares similares
-
Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response
por: Petreus, Tudor, et al.
Publicado: (2021) -
Microengineered Multi‐Organoid System from hiPSCs to Recapitulate Human Liver‐Islet Axis in Normal and Type 2 Diabetes
por: Tao, Tingting, et al.
Publicado: (2021) -
A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models
por: Singh, Dharaminder, et al.
Publicado: (2022) -
Advances of Exosomal miRNAs in Breast Cancer Progression and Diagnosis
por: Chen, Wenwen, et al.
Publicado: (2021) -
SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip
por: Guo, Yaqiong, et al.
Publicado: (2021)